PATENT CLAIM ANALYSIS

Application Number: 16315263
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "275000"]

Abstract:
Provided is a pharmaceutical composition for preventing and treating tumors, the pharmaceutical composition including an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition is administered to an entity which has developed a tumor or is in danger of developing a tumor, and thus tumors can be prevented or treated.

Claim (Index 9):
The pharmaceutical composition of  claim 6 , wherein the tumors are selected from the group consisting of lung cancer, liver cancer, esophageal cancer, stomach cancer, colorectal cancer, small intestine cancer, pancreatic cancer, melanoma, breast cancer, oral cancer, brain tumor, thyroid cancer, parathyroid cancer, renal cancer, cervical cancer, sarcoma, prostate cancer, urethral cancer, bladder cancer, testicular cancer, hematological malignancy, lymphoma, skin cancer, psoriasis, and fibroadenoma.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 99.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12274834', '14436145', '15841902', '13509442', '13506510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047397545976481
- 35 USC 102 Novelty (BERT): 0.5403017026449581
- Combined Prediction Score: 0.7782959494023792
- Mean Citation Score: 333.91248600000006
- Max Citation Score: 374.03793
- Similarity Product: 218.417904596268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test